This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Xiang Nu - Innovator in Immunological Adjuvants
Introduction
Xiang Nu is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of immunology, particularly in the development of compounds that serve as immunological adjuvants. His work is crucial for enhancing the efficacy of vaccines against bacterial and viral diseases.
Latest Patents
Xiang Nu holds 1 patent for his invention titled "Compounds for preparing immunological adjuvant." This patent provides methods for preparing TLR-4 receptor agonist E6020 and its stereoisomers. These compounds are designed to be used as immunological adjuvants when co-administered with antigens, such as vaccines, to improve immune responses.
Career Highlights
Xiang Nu is currently employed at Eisai R&D Management Co., Ltd. His work at this company focuses on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and application of immunological adjuvants.
Collaborations
Xiang has collaborated with notable colleagues, including Lynn D. Hawkins and James E. Foy. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Xiang Nu's work in immunological adjuvants represents a significant advancement in vaccine technology. His innovative approach and dedication to research continue to impact the field positively.